Galantamine as benzofuro-benzazepine alkaloid used in cognition and dementia

Authors

  • Dr. Dhrubo Jyoti Sen Professor, Department of Pharmaceutical Chemistry, Shri Sarvajanik Pharmacy College, Gujarat Technological University, Arvind Baug, Mehsana-384001, Gujarat, India

Keywords:

Benzazepine, Cognition, Dementia, Acetyl cholinesterase

Abstract

Galantamine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Galantamine is in a class of medications called acetyl cholinesterase inhibitors. It works by increasing the amount of a certain natural substance in the brain that is needed for memory and thought. Galantamine may improve the ability to think and remember or slow the loss of these abilities in people who have AD. However, galantamine will not cure AD or prevent the loss of mental abilities at some time in the future.

Downloads

Published

2017-03-29

How to Cite

Dr. Dhrubo Jyoti Sen. (2017). Galantamine as benzofuro-benzazepine alkaloid used in cognition and dementia. World Journal of Pharmaceutical Sciences, 5(4), 1–5. Retrieved from https://wjpsonline.com/index.php/wjps/article/view/galantamine-benzofuro-benzazepine-alkaloid-dementia

Issue

Section

Editorial

Most read articles by the same author(s)